These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34174151)

  • 1. Correcting the sex disparity in MELD-Na.
    Wood NL; VanDerwerken D; Segev DL; Gentry SE
    Am J Transplant; 2021 Oct; 21(10):3296-3304. PubMed ID: 34174151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex Disparity in Liver Transplant and Access to Living Donation.
    Karnam RS; Chen S; Xu W; Chen C; Elangainesan P; Ghanekar A; McGilvray I; Reichman T; Sayed B; Selzner M; Sapisochin G; Galvin Z; Hirschfield G; Asrani SK; Selzner N; Cattral M; Lilly L; Bhat M
    JAMA Surg; 2021 Nov; 156(11):1010-1017. PubMed ID: 34406347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation.
    Allen AM; Heimbach JK; Larson JJ; Mara KC; Kim WR; Kamath PS; Therneau TM
    Transplantation; 2018 Oct; 102(10):1710-1716. PubMed ID: 29620614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Awarding additional MELD points to the shortest waitlist candidates improves sex disparity in access to liver transplant in the United States.
    Bernards S; Lee E; Leung N; Akan M; Gan K; Zhao H; Sarkar M; Tayur S; Mehta N
    Am J Transplant; 2022 Dec; 22(12):2912-2920. PubMed ID: 35871752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
    Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
    Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
    Atiemo K; Skaro A; Maddur H; Zhao L; Montag S; VanWagner L; Goel S; Kho A; Ho B; Kang R; Holl JL; Abecassis MM; Levitsky J; Ladner DP
    Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
    Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
    Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MELD is MELD is MELD? Transplant center-level variation in waitlist mortality for candidates with the same biological MELD.
    Ishaque T; Kernodle AB; Motter JD; Jackson KR; Chiang TP; Getsin S; Boyarsky BJ; Garonzik-Wang J; Gentry SE; Segev DL; Massie AB
    Am J Transplant; 2021 Oct; 21(10):3305-3311. PubMed ID: 33870635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region 11 MELD Na exception prospective study.
    Fisher RA; Heuman DM; Harper AM; Behnke MK; Smith AD; Russo MW; Zacks S; McGillicuddy JW; Eason J; Porayko MK; Northup P; Marvin MR; Hundley J; Nair S
    Ann Hepatol; 2012; 11(1):62-7. PubMed ID: 22166562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELD-GRAIL-Na: Glomerular Filtration Rate and Mortality on Liver-Transplant Waiting List.
    Asrani SK; Jennings LW; Kim WR; Kamath PS; Levitsky J; Nadim MK; Testa G; Leise MD; Trotter JF; Klintmalm G
    Hepatology; 2020 May; 71(5):1766-1774. PubMed ID: 31523825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying Sex-Based Disparities in Liver Allocation.
    Locke JE; Shelton BA; Olthoff KM; Pomfret EA; Forde KA; Sawinski D; Gray M; Ascher NL
    JAMA Surg; 2020 Jul; 155(7):e201129. PubMed ID: 32432699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Body Surface Area With Access to Deceased Donor Liver Transplant and Novel Allocation Policies.
    Kling CE; Biggins SW; Bambha KM; Feld LD; Perkins JH; Reyes JD; Perkins JD
    JAMA Surg; 2023 Jun; 158(6):610-616. PubMed ID: 36988928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure.
    Hernaez R; Liu Y; Kramer JR; Rana A; El-Serag HB; Kanwal F
    J Hepatol; 2020 Dec; 73(6):1425-1433. PubMed ID: 32531416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study.
    Malamon JS; Kaplan B; Jackson WE; Saben JL; Schold JD; Pomfret EA; Pomposelli JJ
    Int J Surg; 2023 Sep; 109(9):2714-2720. PubMed ID: 37226874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Model for End-stage Liver Disease sodium (MELD-Na) score in the Eurotransplant region.
    Goudsmit BFJ; Putter H; Tushuizen ME; de Boer J; Vogelaar S; Alwayn IPJ; van Hoek B; Braat AE
    Am J Transplant; 2021 Jan; 21(1):229-240. PubMed ID: 32529758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of creatinine values on MELD scores in male and female candidates for liver transplantation.
    Mariante-Neto G; Marroni CP; Fleck Junior AM; Marroni CA; Zanotelli ML; Cantisani G; Brandão AB
    Ann Hepatol; 2013; 12(3):434-9. PubMed ID: 23619260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort study.
    Rodríguez-Perálvarez ML; Gómez-Orellana AM; Majumdar A; Bailey M; McCaughan GW; Gow P; Guerrero M; Taylor R; Guijo-Rubio D; Hervás-Martínez C; Tsochatzis EA
    Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):242-252. PubMed ID: 36528041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.